Research ArticleAnnual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), Toronto, Canada, July 12–13, 2013
GRAPPA Treatment Recommendations: An Update from the GRAPPA 2013 Annual Meeting
Laura C. Coates, Christopher T. Ritchlin and Arthur F. Kavanaugh
The Journal of Rheumatology June 2014, 41 (6) 1237-1239; DOI: https://doi.org/10.3899/jrheum.140179
Laura C. Coates
From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds,
UK; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York; and the University of California at San Diego, California,
USA.
Christopher T. Ritchlin

REFERENCES
- 1.↵
- Kavanaugh AF,
- Ritchlin CT
- 2.↵
- Ritchlin CT,
- Kavanaugh A,
- Gladman DD,
- Mease PJ,
- Helliwell P,
- Boehncke WH,
- et al.
- 3.↵National Collaborating Centre for Methods and Tools (2011). Critically appraising practice guidelines: The AGREE II instrument. Hamilton, ON: McMaster University. (Updated 01 November, 2013). [Internet. Accessed March 26, 2014.] Available from: www.nccmt.ca/registry/view/eng/100.html
- 4.↵The Grading of Recommendations Assessment, Development and Evaluation (short GRADE) Working Group. [Internet. Accessed March 26, 2014.] Available from: www.gradeworkinggroup.org/
In this issue
The Journal of Rheumatology
Vol. 41, Issue 6
1 Jun 2014
GRAPPA Treatment Recommendations: An Update from the GRAPPA 2013 Annual Meeting
Laura C. Coates, Christopher T. Ritchlin, Arthur F. Kavanaugh
The Journal of Rheumatology Jun 2014, 41 (6) 1237-1239; DOI: 10.3899/jrheum.140179